Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Levine

Showing results (31-40 of 132) with videos related to

Pageof 14
Sort By:
Seminars in Thrombosis and Hemostasis|June 5, 1999
The thrombophilic state induced by therapeutic agents in the cancer patientA Y Lee, M N Levine
Gynecologic Oncology|June 30, 2000
Better treatments that cost more: the dilemmaL Elit, A Gafni, M N Levine
Drugs|November 1, 1985
Risk of haemorrhage associated with long term anticoagulant therapyM N Levine, G Raskob, J Hirsh
Chest|February 1, 1989
Hemorrhagic complications of long-term anticoagulant therapyM N Levine, G Raskob, J Hirsh
Chest|February 1, 1986
Hemorrhagic complications of long-term anticoagulant therapyM N Levine, G Raskob, J Hirsh
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Economic and policy implications of adopting paclitaxel as first-line therapy for advanced ovarian cancer: an Ontario perspectiveL M Elit, A Gafni, M N Levine
Chest|February 1, 1989
Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolismA G Fennerty, M N Levine, J Hirsh
Archives of Internal Medicine|February 1, 1986
Heroin vs morphine for cancer pain?M N Levine, D L Sackett, H Bush
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1986
Analysis of dose intensity for chemotherapy in early (stage II) and advanced breast cancerW M Hryniuk, M N Levine, L Levin
Chest|September 1, 1994
Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism GroupS Z Goldhaber, G Agnelli, M N Levine
Pageof 14

Showing results (31-40 of 132) with videos related to

Sort By:
Pageof 14
Seminars in Thrombosis and Hemostasis|June 5, 1999
The thrombophilic state induced by therapeutic agents in the cancer patientA Y Lee, M N Levine
Gynecologic Oncology|June 30, 2000
Better treatments that cost more: the dilemmaL Elit, A Gafni, M N Levine
Drugs|November 1, 1985
Risk of haemorrhage associated with long term anticoagulant therapyM N Levine, G Raskob, J Hirsh
Chest|February 1, 1989
Hemorrhagic complications of long-term anticoagulant therapyM N Levine, G Raskob, J Hirsh
Chest|February 1, 1986
Hemorrhagic complications of long-term anticoagulant therapyM N Levine, G Raskob, J Hirsh
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Economic and policy implications of adopting paclitaxel as first-line therapy for advanced ovarian cancer: an Ontario perspectiveL M Elit, A Gafni, M N Levine
Chest|February 1, 1989
Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolismA G Fennerty, M N Levine, J Hirsh
Archives of Internal Medicine|February 1, 1986
Heroin vs morphine for cancer pain?M N Levine, D L Sackett, H Bush
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1986
Analysis of dose intensity for chemotherapy in early (stage II) and advanced breast cancerW M Hryniuk, M N Levine, L Levin
Chest|September 1, 1994
Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism GroupS Z Goldhaber, G Agnelli, M N Levine
Pageof 14